Redhill Biopharma Ltd. ADR (RDHL) concluded trading on Wednesday at a closing price of $2.07, with 6.25 million shares of worth about $12.94 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -74.06% during that period and on April 16, 2025 the price saw a loss of about -3.04%. Currently the company’s common shares owned by public are about 1.27M shares, out of which, 1.27M shares are available for trading.
Stock saw a price change of -23.33% in past 5 days and over the past one month there was a price change of -27.62%. Year-to-date (YTD), RDHL shares are showing a performance of -66.67% which decreased to -79.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.80 but also hit the highest price of $20.27 during that period. The average intraday trading volume for Redhill Biopharma Ltd. ADR shares is 94.19K. The stock is currently trading -17.91% below its 20-day simple moving average (SMA20), while that difference is down -40.24% for SMA50 and it goes to -70.98% lower than SMA200.
Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) currently have 1.27M outstanding shares and institutions hold larger chunk of about 6.49% of that.
The stock has a current market capitalization of $2.63M and its 3Y-monthly beta is at 4.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RDHL, volatility over the week remained 17.26% while standing at 11.56% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on August 31, 2021 offering an Overweight rating for the stock and assigned a target price of $22 to it. Coverage by H.C. Wainwright stated Redhill Biopharma Ltd. ADR (RDHL) stock as a Buy in their note to investors on May 18, 2021, suggesting a price target of $23 for the stock. Stock get a Buy rating from WBB Securities on March 12, 2019.
